Jun 2026 (Q2 FY26) — Aug 6, 2026
Teads Q2 FY26 — Enterprise Growth and CTV Acceleration Offset DR/SME Headwinds
Read the full callTeads (TEAD) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Teads earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 285 | −17.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -5.5 | −4.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -42.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$0.41 +2.50% · +$0.01
Performance −71.5% 1Y
1Y: $1.44 on 17 Oct 2025 → $0.41. High $1.72 (27 Oct 2025), low $0.4 (16 Oct 2026).
- Previous close
- $0.4
- 52-week range
- $0.4 – $1.72
- One year
- −74.05%
Overview
- Symbol
- TEAD
- Sector
- Communication Services
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Teads earnings calls (TEAD)
Financials
What the filings say
Net profit, year on year: −197% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 224 | 235 | 286 | 343 | 319 | 352 | 266 | 285 |
| Operating profit | -3 | 3 | -44 | -2 | -6 | -346 | -22 | -16 |
| Operating margin | −1.3% | 1.1% | −15.5% | −0.7% | −2.0% | −98.2% | −8.2% | −5.5% |
| Other income | 11 | 1 | -24 | -18 | -18 | -19 | -18 | -20 |
| Interest | 1 | 1 | 23 | 18 | 17 | 17 | 17 | 17 |
| Profit before tax | 8 | 3 | -68 | -20 | -24 | -365 | -40 | -35 |
| Tax rate | 15.5% | 105.0% | 19.4% | 28.7% | 19.2% | −17.3% | 2.5% | −20.8% |
| Net profit | 7 | -0 | -55 | -14 | -20 | -428 | -39 | -42 |
| EPS ($ per share) | 0.14 | — | -0.70 | -0.15 | -0.21 | — | -0.40 | -0.44 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -168 | -157 | -179 | -169 | -169 | -687 |
| Total liabilities | — | 274 | 539 | 563 | 442 | 318 | 1,233 |
| Fixed assets | — | 25 | 28 | 40 | 42 | 45 | 51 |
| Investments | — | — | 0 | 167 | 94 | 77 | 10 |
| Total assets | — | 356 | 796 | 781 | 665 | 549 | 1,328 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 17 | 53 | 57 | 4 | 14 | 69 | 8 |
| Cash from investing | -8 | -9 | -20 | -318 | 70 | 67 | -554 |
| Cash from financing | -4 | -4 | 326 | -32 | -117 | -118 | 585 |
| Net cash flow | 6 | 44 | 362 | -350 | -35 | 19 | 40 |
| Capital expenditure | -2 | -2 | -10 | -13 | -10 | -7 | -6 |
| Free cash flow | 14 | 51 | 47 | -10 | 4 | 61 | 2 |
Insider filings
50 filings between Dec 7, 2025 and Sep 5, 2026.
Open market
decisions to buy or sellPurchases
$164.5K
6 purchases by 3 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 14
- Award — granted as compensation
- 30
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Spilman Mary | $104.0K | — | May 18, 2026 |
| Kostman David | $53.3K | — | Jun 2, 2026 |
| Krindel Yaffa | $7.3K | — | Dec 12, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 2,104 | $1.1K |
| Sep 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 5,742 | $2.9K |
| Sep 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 378 | $189 |
| Sep 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 3,540 | $1.8K |
| Sep 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 306 | $153 |
| Sep 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 94 | $47 |
| Jun 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 378 | $461 |
| Jun 5, 2026 | Kostman David Chief Executive Officer | Tax withheld | 7,870 | $9.1K |
| Jun 5, 2026 | Kostman David Chief Executive Officer | Tax withheld | 6,716 | $7.7K |
| Jun 5, 2026 | Kostman David Chief Executive Officer | Tax withheld | 28,411 | $34.7K |
| Jun 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 6,731 | $7.7K |
| Jun 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 94 | $108 |
| Jun 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 9,571 | $11.7K |
| Jun 5, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 3,232 | $3.7K |
| Jun 5, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 306 | $352 |
| Jun 2, 2026 | Kostman David Chief Executive Officer | Purchase | 13,500 | $14.4K |
| Jun 1, 2026 | Kostman David Chief Executive Officer | Purchase | 15,000 | $17.9K |
| May 29, 2026 | Kostman David Chief Executive Officer | Purchase | 18,000 | $20.9K |
| May 18, 2026 | Spilman Mary Chief Commercial Officer | Purchase | 105,000 | $104.0K |
| May 13, 2026 | Goei Dexter Director | Award | 20,000 | $0 |
| May 13, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Award | 50,000 | $0 |
| May 13, 2026 | Dovrat Shlomo Director | Award | 20,000 | $0 |
| May 13, 2026 | Krindel Yaffa Director | Award | 20,000 | $0 |
| May 13, 2026 | Taneyhill Jhaveri Kathryn Director | Award | 20,000 | $0 |
| May 13, 2026 | Wolter Arne Director | Award | 20,000 | $0 |
| May 13, 2026 | Kiviat Jason Chief Financial Officer | Award | 120,000 | $0 |
| May 13, 2026 | Kostman David Chief Executive Officer | Award | 324,000 | $0 |
| May 13, 2026 | Galai Yaron Director | Award | 20,000 | $0 |
| May 13, 2026 | Das Nithya B. Director | Award | 20,000 | $0 |
| May 13, 2026 | Mullen Mark Director | Award | 20,000 | $0 |
| May 13, 2026 | Zagorski Mark Director | Award | 20,000 | $0 |
| Mar 11, 2026 | Spilman Mary Chief Commercial Officer | Award | 1,400,000 | $0 |
| Mar 11, 2026 | Porat Asaf Chief Operating Officer | Award | 73,836 | $0 |
| Mar 7, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 340 | $286 |
| Mar 7, 2026 | Kostman David Chief Executive Officer | Tax withheld | 13,680 | $11.5K |
| Mar 7, 2026 | Kostman David Chief Executive Officer | Tax withheld | 11,043 | $9.3K |
| Mar 7, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 2,129 | $1.8K |
| Mar 7, 2026 | Kiviat Jason Chief Financial Officer | Tax withheld | 7,805 | $6.6K |
| Mar 7, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 434 | $365 |
| Mar 7, 2026 | Kostman David Chief Executive Officer | Tax withheld | 7,660 | $6.4K |
| Mar 7, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 1,445 | $1.2K |
| Mar 7, 2026 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 108 | $91 |
| Dec 12, 2025 | Krindel Yaffa Director | Purchase | 1,892 | $1.3K |
| Dec 11, 2025 | Krindel Yaffa Director | Purchase | 8,108 | $6.0K |
| Dec 7, 2025 | Kiviat Jason Chief Financial Officer | Tax withheld | 1,914 | $1.2K |
| Dec 7, 2025 | Kiviat Jason Chief Financial Officer | Tax withheld | 7,018 | $4.3K |
| Dec 7, 2025 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 378 | $231 |
| Dec 7, 2025 | Kiviat Jason Chief Financial Officer | Tax withheld | 306 | $187 |
| Dec 7, 2025 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 1,260 | $769 |
| Dec 7, 2025 | Bradshaw Wenkai CAO & SVP Corporate Controller | Tax withheld | 94 | $57 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Teads Holding Co.
Free account. Everything above stays public.
Write why you follow Teads Holding Co. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading